24/7 Market News Snapshot 10 October, 2024 – Clearmind Medicine Inc. Common Shares (NASDAQ:CMND)

October 10, 2024

DENVER, Colo., 10 October, 2024 (247marketnews.com) – (NASDAQ:CMND) are discussed in this article.
Clearmind Medicine Inc. is currently witnessing significant upward momentum in its stock performance, trading at $1.634 in the pre-market, reflecting a striking increase of 16.71% from the previous closing value of $1.400. This surge is backed by a substantial trading volume of 1.58 million shares, indicating a notable spike in investor interest and positive market sentiment. Analysts suggest that this bullish trend may be influenced by recent advancements within the company, making CMND a noteworthy player in the biotech sector.

The company’s developments are highlighted by its recent receipt of Institutional Review Board (IRB) approval for a Phase I/IIa clinical trial evaluating its innovative therapy, CMND-100, designed to combat alcohol use disorder (AUD). This crucial approval, secured for one of the trial sites in the U.S., allows Clearmind to initiate a multinational study focused on assessing the safety, tolerability, and pharmacokinetics of the MEAI-based compound (5-methoxy-2-aminoindane). The clinical trial will not only take place at Johns Hopkins University but also at Yale School of Medicine and the IMCA Center.

Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine, expressed optimism regarding the IRB approval, referring to it as a significant milestone in advancing the clinical trial aimed at providing effective treatment solutions for those afflicted by AUD. The trial aims to establish a tolerable dosage of CMND-100 and evaluate its safety and pharmacodynamic effects on both healthy volunteers and individuals struggling with AUD.

With an extensive intellectual property portfolio consisting of nineteen patent families, Clearmind Medicine is committed to exploring innovative treatment avenues, positioning itself as a key contributor in addressing pressing global health issues related to alcohol dependency. The company continues to attract attention in the public markets, listed on Nasdaq and the Frankfurt Stock Exchange under the symbols CMND and CWY0, respectively.

Related news for (CMND)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.